NOIDS.wiki
Calcolatore
Negozio Calcolatore di potenza
Scienza della cannabis

THCV (Tetrahydrocannabivarin): Specs, Evidence, Decarb & Infusion

Cannabinoid index · Dose-dependent

Dose-dependent effectNot approvedWADA-prohibitedLiposolubile

THCV (tetrahydrocannabivarin) is a minor cannabinoid and the propyl analog of THC. Its effect is dose-dependent: at low doses it behaves more like a CB1 blocker and is not intoxicating, while at higher doses it can be mildly intoxicating, generally weaker and shorter than THC. It has drawn interest for appetite and metabolic research, with only small early human studies.

Specifica
Composto
THCV (Tetrahydrocannabivarin)
Precursore acido
THCVA
Classificazione
Phytocannabinoid (propyl analog of THC)
Numero CAS
31262-37-0
Formula molecolare
C19H26O2
Peso molecolare
286.41 g/mol
Inebriante
Dose-dependent: not at low doses, mildly at high doses
Solubilità
Liposolubile; scarsamente idrosolubile

Decarbossilazione & infusione

Forma acida
THCVA, the form in raw flower
Decarbossilazione
THCVA converts to THCV with heat over time
Attivazione approssimativa
Broadly similar to THC, roughly 105 to 130°C
Infusione
Fat-soluble, so it transfers into oils and butter
Availability
Present at meaningful levels only in specific cultivars; a trace in most flower

See the tabella delle temperature di decarbossilazione.

Evidenze & stato
Stato di approvazione
Not approved. Not a component of any approved drug.
Stato in Europa
Not authorised. No monograph.
Supporto più solido
Small early human studies plus animal and cell work
Sport agonistico
Prohibited in-competition by WADA (cannabinoids, CBD excepted).
Lavoro di laboratorioStudi sugli animaliHuman studiesIndicazione approvata

Reviewed 2026-09-04. Not legal or medical advice.

Cosa ha esaminato la letteratura pubblicata

THCV’s dose-dependent pharmacology at the CB1 receptor (antagonist at low doses, partial agonist at higher doses) is described in animal and cell studies. There is limited early human work: a small randomised study examined THCV and glycaemic control in people with type 2 diabetes (Jadoon et al., Diabetes Care, 2016). Appetite and metabolic effects are the main research angle, but the human evidence base is small.

Cosa è accertato e cosa no

Accertato: that THCV is a real cannabinoid with dose-dependent CB1 activity, and that a small human study has been conducted. Non accertato: any approved use or robust clinical benefit; the human evidence is early and small. Marketing that frames THCV as a proven appetite suppressant or “diet weed” overstates it. This page describes the compound and summarises research; it is not medical advice.

Fonti

  • Jadoon KA, et al. Efficacy and Safety of Cannabidiol and Tetrahydrocannabivarin on Glycemic and Lipid Parameters in Type 2 Diabetes. Diabetes Care. 2016;39:1777-1786. PubMed
  • Pertwee RG. The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: THC, CBD and THCV. Br J Pharmacol. 2008;153:199-215. PubMed
  • Registered human studies for tetrahydrocannabivarin. ClinicalTrials.gov
  • World Anti-Doping Agency. Prohibited List (cannabinoids, CBD excepted). wada-ama.org

Domande frequenti

Does THCV get you high?

It depends on the dose. At low doses THCV behaves more like a CB1 blocker and is not intoxicating; at higher doses it can be mildly intoxicating, generally weaker and shorter than THC.

Is THCV “diet weed”?

That nickname comes from appetite and metabolic research, but the human evidence is small and early. It is not a proven appetite suppressant.

Why is THCV rare?

Most cannabis contains only a trace. Meaningful levels appear in specific cultivars, which is why THCV-rich products are uncommon.

Parte del indice dei cannabinoidi.

Educational information about a compound. Not medical advice or guidance on use.

Questo articolo è solo a scopo educativo. Segui sempre le leggi locali riguardo la preparazione e l'uso della cannabis.

Scroll to Top